AArete appointed Jeff Berger as vice president of strategy and corporate development and Dr. Danielle Smith as vice president of clinical intelligence. The move signals continued investment in AI/clinical intelligence capabilities, but no financial impact or guidance changes were provided.
AArete appointed Jeff Berger as vice president of strategy and corporate development and Dr. Danielle Smith as vice president of clinical intelligence. The move signals continued investment in AI/clinical intelligence capabilities, but no financial impact or guidance changes were provided.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.10
